Cargando…
Response to Michael Wonder’s comments on the article ‘Assessment of the therapeutic value of new medicines marketed in Australia’
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4366930/ https://www.ncbi.nlm.nih.gov/pubmed/25848537 http://dx.doi.org/10.1186/2052-3211-6-8 |
| _version_ | 1782362451316047872 |
|---|---|
| author | Vitry, Agnes I |
| author_facet | Vitry, Agnes I |
| author_sort | Vitry, Agnes I |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4366930 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2013 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-43669302015-04-06 Response to Michael Wonder’s comments on the article ‘Assessment of the therapeutic value of new medicines marketed in Australia’ Vitry, Agnes I J Pharm Policy Pract Letter to the Editor BioMed Central 2013-10-10 /pmc/articles/PMC4366930/ /pubmed/25848537 http://dx.doi.org/10.1186/2052-3211-6-8 Text en Copyright © 2013 Vitry; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Letter to the Editor Vitry, Agnes I Response to Michael Wonder’s comments on the article ‘Assessment of the therapeutic value of new medicines marketed in Australia’ |
| title | Response to Michael Wonder’s comments on the article ‘Assessment of the therapeutic value of new medicines marketed in Australia’ |
| title_full | Response to Michael Wonder’s comments on the article ‘Assessment of the therapeutic value of new medicines marketed in Australia’ |
| title_fullStr | Response to Michael Wonder’s comments on the article ‘Assessment of the therapeutic value of new medicines marketed in Australia’ |
| title_full_unstemmed | Response to Michael Wonder’s comments on the article ‘Assessment of the therapeutic value of new medicines marketed in Australia’ |
| title_short | Response to Michael Wonder’s comments on the article ‘Assessment of the therapeutic value of new medicines marketed in Australia’ |
| title_sort | response to michael wonder’s comments on the article ‘assessment of the therapeutic value of new medicines marketed in australia’ |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4366930/ https://www.ncbi.nlm.nih.gov/pubmed/25848537 http://dx.doi.org/10.1186/2052-3211-6-8 |
| work_keys_str_mv | AT vitryagnesi responsetomichaelwonderscommentsonthearticleassessmentofthetherapeuticvalueofnewmedicinesmarketedinaustralia |